Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MAMH - New Breast Cancer detection method -- Ignore unavailable to you. Want to Upgrade?

To: DuGen who wrote (850)	1/5/1999 9:56:00 PM
From: Hubert Few	Respond to of 971

DuGen said:"BZET used to be a $17 stock and now going for 25 cents. Is the threat of being delisted part of the cause?" Absolutely the threat of delisting is the major reason for decline. From there the story gets a lot better! For the price of many "penny stocks" BZET has real patents, a real diagnostic device that has been approved for sale in Europe, and lots of positive press. "It does look like it might be turning around from down there, but I need more information." You could start here if you choose to: "https://www.siliconinvestor.com/subject.aspx?subjectid=24295 Best Wishes!